Revelation Partners logo

Revelation Partners

North America, California, United States, San Francisco

Description

Revelation Partners is a specialized healthcare investment firm based in San Francisco, California, known for its dual approach to capital deployment. The firm primarily focuses on providing liquidity solutions and growth capital to leading companies within the expansive healthcare sector. Their investment scope is broad, encompassing various sub-sectors such as biotechnology, pharmaceuticals, medical devices, diagnostics, digital health, and healthcare services, demonstrating a comprehensive understanding of the industry's diverse needs.

A significant part of Revelation Partners' strategy involves direct investments into growth-stage healthcare companies. These investments are often structured to provide liquidity to founders, early investors, and employees, enabling them to realize value while supporting the continued growth of the underlying businesses. The firm is recognized for its flexible investment approach, tailoring solutions to meet specific company and shareholder requirements. Their typical direct investment check sizes range from $10 million to $100 million, indicating a focus on substantial, impactful capital injections.

Beyond direct investments, Revelation Partners also allocates capital to healthcare-focused venture capital funds, operating as a fund of funds. This complementary strategy allows them to gain diversified exposure to emerging healthcare innovations and support the broader ecosystem of healthcare entrepreneurship. Since its inception, Revelation Partners has deployed over $2 billion across more than 100 healthcare companies and funds, underscoring their significant footprint and long-standing commitment to the healthcare investment landscape. This extensive track record highlights their expertise and deep network within the sector, positioning them as a key partner for healthcare innovators and investors alike.

Investor Profile

Revelation Partners has backed more than 49 startups, with 2 new investments in the last 12 months alone. The firm has led 5 rounds, about 10% of its total and boasts 10 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series Unknown, Series C rounds (top funding stages).
  • Majority of deals are located in United States, Brazil, Ireland.
  • Strong thematic focus on Health Care, Medical, Biotechnology.
  • Typical check size: $10M – $100M.

Stage Focus

  • Series B (24%)
  • Series Unknown (20%)
  • Series C (18%)
  • Series E (14%)
  • Series D (10%)
  • Series F (4%)
  • Series G (2%)
  • Series A (2%)
  • Convertible Note (2%)
  • Private Equity (2%)

Country Focus

  • United States (90%)
  • Brazil (4%)
  • Ireland (2%)
  • United Kingdom (2%)
  • Switzerland (2%)

Industry Focus

  • Health Care
  • Medical
  • Biotechnology
  • Medical Device
  • Therapeutics
  • Life Science
  • Software
  • Pharmaceutical
  • Information Technology
  • Hospital
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Revelation Partners frequently co-invest with?

Pfizer
North America, New York, United States, New York
Co-Investments: 3
Kaiser Permanente Ventures
North America, California, United States, Oakland
Co-Investments: 6
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 4
Essex Woodlands Healthcare Partners
North America, California, United States, Palo Alto
Co-Investments: 3
Ally Bridge Group
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 4
FirstMark
North America, New York, United States, New York
Co-Investments: 4
SR One
North America, Massachusetts, United States, Cambridge
Co-Investments: 3
Split Rock Partners
North America, Minnesota, United States, Minneapolis
Co-Investments: 4
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 4
AXA Venture Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 4

Which angels does Revelation Partners often collaborate with?

RS
North America, California, United States, San Francisco
Shared Deals: 1
PH
North America, Nebraska, United States, Omaha
Shared Deals: 1
SS
North America, California, United States, Los Angeles
Shared Deals: 1
LH
North America, Nebraska, United States, Omaha
Shared Deals: 1
BB
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Revelation Partners?

Arbor Biotechnologies

Cambridge, Massachusetts, United States

Arbor Biotechnologies is a biotechnology company specializing in next-generation gene editing therapeutics to treat genetic diseases.

BiopharmaBiotechnologyLife Science
Series CMar 18, 2025
Amount Raised: $73,900,000
VitalConnect

San Jose, California, United States

VitalConnect offers wearable biosensor technology for wireless patient monitoring in both hospital and remote patient populations.

BiotechnologyHealth CareMedical DeviceWearables
Series UnknownFeb 19, 2025
Amount Raised: $100,000,000
SPR Therapeutics

Cleveland, Ohio, United States

SPR Therapeutics is a medical device company.

HardwareHealth CareMedicalTherapeutics
Series DFeb 1, 2024
Amount Raised: $25,000,000
Nouscom

Basel, Basel-Stadt, Switzerland

Nouscom is a biotech company working to develop a series of immunotherapeutics capable of selectively killing tumor cells.

BiotechnologyGeneticsHealth CareTherapeutics
Series CNov 14, 2023
Amount Raised: $73,425,672
VitalConnect

San Jose, California, United States

VitalConnect offers wearable biosensor technology for wireless patient monitoring in both hospital and remote patient populations.

BiotechnologyHealth CareMedical DeviceWearables
Series FJul 18, 2023
Amount Raised: $30,000,000
Carrum Health

San Francisco, California, United States

Carrum Health is a value-based centers of platform that ensures patients receive quality and less expensive care.

Health CareHospitalHuman ResourcesWellness
Series BMay 30, 2023
Amount Raised: $45,000,000
Vedanta Biosciences

Cambridge, Massachusetts, United States

Vedanta Biosciences creates microbiome-derived therapies to address immune and infectious diseases by modulating the gut microbiota.

BiotechnologyBusiness DevelopmentMedical
Series EApr 25, 2023
Amount Raised: $106,500,000
Bristol Hospice

Salt Lake City, Utah, United States

Operates and manages hospice programs in seven states.

Health CareHospital
Series UnknownJan 1, 2023
Carrick Therapeutics

Dublin, Dublin, Ireland

Carrick Therapeutics is a developer of cancer therapeutics intended to transform the way cancer is treated.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series CDec 1, 2022
Amount Raised: $60,000,000
Syapse

San Francisco, California, United States

Syapse is a real-world evidence company dedicated to extinguishing the fear and burden of serious disease by advancing real-world care

Big DataBioinformaticsCloud ComputingHealth CareInformation ServicesInformation TechnologyPrecision Medicine
Series UnknownJul 27, 2022
Amount Raised: $35,000,000